封面
市場調查報告書
商品編碼
1777666

全球獸醫循環系統市場

Veterinary Cardiology

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 466 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年,全球獸醫循環系統市場美國將達到 42 億美元

全球獸醫循環系統市場規模預計在2024年達到27億美元,預計2024年至2030年期間的複合年成長率為7.5%,到2030年將達到42億美元。伴侶動物是本報告分析的細分市場之一,預計其複合年成長率為8.8%,到分析期結束時規模將達到28億美元。生產性動物細分市場在分析期間的複合年成長率預計為5.0%。

美國市場規模估計為 7.374 億美元,而中國市場預計複合年成長率為 11.9%

美國獸醫循環系統市場規模預計在2024年達到7.374億美元。作為世界第二大經濟體,中國預計到2030年市場規模將達到8.936億美元,在2024-2030年的分析期間內,複合年成長率為11.9%。其他值得關注的區域市場包括日本和加拿大,預計在分析期間內,這兩個市場的複合年成長率分別為3.6%和7.3%。在歐洲,預計德國市場的複合年成長率為4.9%。

全球獸醫循環系統市場—主要趨勢和促進因素摘要

為什麼獸醫循環系統成為伴侶動物醫療保健的支柱?

隨著伴侶動物心臟相關疾病的發生率不斷上升,以及寵物飼主對早期診斷和持續心臟護理重要性的認知不斷提高,獸醫循環系統正逐漸成為動物保健領域的重要專業。隨著營養改善、預防保健和先進醫療手段的運用,寵物壽命不斷延長,與老齡化相關的心血管疾病(如鬱血性心臟衰竭衰竭、心律不整、瓣膜疾病和先天性畸形)也變得越來越常見。騎士查理王獵犬、拳師犬和杜賓犬等犬種以及某些貓種,在遺傳上易患心臟病,需要接受專門治療。獸醫心臟科醫生和全科醫生都發現,越來越多的動物病例需要進行診斷檢測,包括超音波心動圖、心電圖 (ECG)、X光成像和心臟生物標記檢測。隨著寵物飼主擴大將他們的動物視為家庭成員,他們更願意尋求先進的診斷和治療性介入,以提高生活品質並延長壽命。對動物健康和專科護理的日益重視,導致世界各地的都市區診所、專科醫院和學術動物醫院對獸醫循環系統服務的需求大幅增加。

診斷和影像方面的創新如何改善動物的心臟照護?

技術創新正在改變獸醫循環系統,使動物心血管疾病的早期發現、更準確的診斷和更好的監測成為可能。最新的超音波心動圖設備現在提供專為獸醫用途客製化的高解析度多普勒影像,使臨床醫生能夠高精度地評估血流、瓣膜功能和心室大小。可攜式無線網路系統促進了照護端和家庭心率分析,改善了全科診所和行動服務中診斷服務的可及性。 NT-proBNP 和肌鈣蛋白等心臟生物標記擴大被用於篩檢、分期和監測心臟疾病,為診斷成像提供了微創補充。 3D 超音波心動圖、電腦斷層掃描 (CT) 和磁振造影(MRI) 等先進影像工具在獸醫轉診中心越來越普遍,尤其是對於複雜病例。遠端醫療在獸醫循環系統領域也發揮著越來越重要的作用,使執業醫師能夠遠距諮詢專家,並快速解讀心電圖和超音波心動圖結果。這些技術發展簡化了工作流程,提高了臨床準確性,最終有助於更有效地管理獸醫心臟病患者,改善其治療效果。

為什麼獸醫和專科醫院要擴大心臟病學服務?

獸醫院、專科醫院和學術中心正在加大心臟病學服務的投資,以滿足日益成長的專科護理需求,並為複雜病例提供全方位的綜合護理。綜合獸醫院正在將聽診訓練、掌上超音波設備和心電圖等基本心臟篩檢工具納入身體檢查和麻醉前篩檢中,以幫助發現心臟疾病的早期跡象。轉診醫院和專科醫院則更進一步,設立了配備委員會認證專家和最先進診斷實驗室的專門心臟科。這些中心不僅提供診斷,還透過長期藥物治療、心律調節器植入、液體管理通訊協定以及必要時的手術干預來治療慢性心臟疾病。大學獸醫學院正在加強心臟病學課程,擴大比較心臟病學、藥物開發和先天性心臟疾病修復的研究。此外,與製藥和醫療設備公司的合作正在推動針對小動物的新型治療方法的開發。提供先進心臟護理的競爭診所正在通過滿足寵物醫療這一日益成長的領域而獲得競爭優勢,該領域受到寵物飼主的高度重視,並且通常需要後續訪問、持續監測和個性化治療計劃,從而建立更牢固的客戶關係並提高患者的終身價值。

推動獸醫循環系統市場全球成長的因素是什麼?

獸醫循環系統市場的成長受到多種相互關聯的因素驅動,包括寵物數量動態、技術進步、臨床創新以及對高級動物護理日益成長的投資意願。關鍵促進因素是全球寵物擁有量的增加以及寵物人性化趨勢的日益成長,這提高了人們對心臟病等慢性和與老齡化相關的疾病的認知。更準確、更實惠的診斷工具的出現使全科醫生能夠在疾病週期的早期對患者篩檢並將其轉診進行專門的心臟評估。動物用藥品的進步,特別是在血管緊張素轉換酶 (ACE) 抑制劑、 BETA阻斷劑、利尿劑和新型心臟藥物領域的進步,使得對心臟病的長期管理更加有效。專科醫療設施和獸醫循環系統培訓計畫的擴展有助於縮小專家就診機會的差距,尤其是在都市區。此外,寵物保險的廣泛普及使更多人能夠以更經濟的方式獲得高級心臟護理。研究合作和臨床試驗也在加速藥物開發和治療通訊協定。這些因素共同作用,將獸醫循環系統從小眾專業轉變為綜合寵物醫療保健的主流領域,並對診所的結構、獸醫專業人員的培訓以及寵物的護理方式產生越來越大的影響。

部分

動物類型(伴侶動物、生產動物);產品(藥品、診斷);適應症(鬱血性、心肌病變、心律不整、其他);最終使用者(獸醫院和診所、其他)

受訪公司範例

  • ALBA Medical Systems, Inc.
  • Antech Diagnostics
  • Boehringer Ingelheim International
  • Bionet America
  • Ceva Sante Animale
  • Cronus Pharma
  • Dextronix
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • IDEXX Laboratories
  • IMV Technologies
  • Infiniti Medical
  • Jurox
  • Medtronic
  • Merck & Co., Inc.
  • Patterson Veterinary
  • Pet Cardiology
  • RHC Medical
  • Scapa Healthcare

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範,而是建立了一個從世界各地專家收集的內容庫,包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況(成品和原始OEM)預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手,包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP33249

Global Veterinary Cardiology Market to Reach US$4.2 Billion by 2030

The global market for Veterinary Cardiology estimated at US$2.7 Billion in the year 2024, is expected to reach US$4.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Companion Animals, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Production Animals segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$737.4 Million While China is Forecast to Grow at 11.9% CAGR

The Veterinary Cardiology market in the U.S. is estimated at US$737.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$893.6 Million by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Veterinary Cardiology Market - Key Trends & Drivers Summarized

Why Is Veterinary Cardiology Becoming a Pillar of Companion Animal Healthcare?

Veterinary cardiology is emerging as a crucial specialty in animal healthcare, driven by the increasing prevalence of heart-related conditions in companion animals and rising awareness among pet owners about the importance of early diagnosis and ongoing cardiac care. As pets live longer due to better nutrition, preventive care, and advanced medical treatments, age-related cardiovascular diseases-including congestive heart failure, arrhythmias, valve disorders, and congenital anomalies-are becoming more common. Dog breeds such as Cavalier King Charles Spaniels, Boxers, and Doberman Pinschers, as well as certain cat breeds, are genetically predisposed to heart issues, necessitating specialized care. Veterinary cardiologists and general practitioners alike are seeing a growing caseload of animals requiring diagnostics like echocardiography, electrocardiograms (ECGs), radiographic imaging, and cardiac biomarker testing. Pet owners, increasingly viewing their animals as family members, are more willing to pursue advanced diagnostic and therapeutic interventions to improve quality of life and extend longevity. This growing emphasis on animal wellness and specialized care is significantly expanding the demand for veterinary cardiology services across urban clinics, specialty hospitals, and academic veterinary centers worldwide.

How Are Innovations in Diagnostics and Imaging Enhancing Cardiac Care for Animals?

Technological innovation is reshaping veterinary cardiology, enabling earlier detection, more accurate diagnosis, and better monitoring of cardiovascular diseases in animals. Modern echocardiography machines now offer high-resolution, Doppler-based imaging tailored for veterinary use, allowing clinicians to assess blood flow, valve function, and chamber dimensions with high precision. Portable and wireless ECG systems are making it easier to perform heart rhythm analysis in clinical or even home-based settings, improving access to diagnostics in general practices and mobile services. Cardiac biomarkers such as NT-proBNP and troponin are being increasingly utilized for screening, staging, and monitoring heart disease, providing a minimally invasive complement to imaging diagnostics. Advanced imaging tools like 3D echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI) are becoming more prevalent in veterinary referral centers, especially for complex cases. Telemedicine is also playing a growing role in veterinary cardiology, enabling practitioners to consult with specialists remotely and receive rapid interpretations of ECGs or echo results. These technological developments are streamlining workflows, enhancing clinical accuracy, and ultimately contributing to more effective management and improved outcomes in veterinary cardiac patients.

Why Are Veterinary Clinics and Specialty Hospitals Expanding Cardiology Services?

Veterinary clinics, specialty hospitals, and academic centers are increasingly investing in cardiology services to meet rising demand for specialized care and to offer full-service, integrated treatment for complex cases. General veterinary practices are incorporating basic cardiac screening tools-such as auscultation training, handheld ultrasound devices, and ECGs-into wellness exams and pre-anesthetic screenings, helping to catch early signs of cardiac disease. Referral and specialty hospitals are going a step further, establishing dedicated cardiology departments with board-certified specialists and state-of-the-art diagnostic suites. These centers are not only diagnosing but also managing chronic cardiac conditions with long-term pharmacologic therapy, pacemaker implantation, fluid management protocols, and surgical interventions when needed. Academic veterinary schools are strengthening cardiology curricula and expanding research in comparative cardiology, drug development, and congenital heart defect repair. Additionally, collaboration with pharmaceutical and medical device companies is leading to the development of new treatment options tailored for small animals. Clinics offering advanced cardiac care are gaining a competitive edge by addressing a growing segment of pet healthcare that is deeply valued by pet owners and often requires repeat visits, ongoing monitoring, and personalized treatment plans-resulting in stronger client relationships and higher lifetime patient value.

What’s Driving the Global Growth of the Veterinary Cardiology Market?

The growth in the veterinary cardiology market is driven by several interrelated factors tied to pet demographics, technological progress, clinical innovation, and increasing consumer willingness to invest in advanced animal care. A significant driver is the global rise in pet ownership and the growing trend of pet humanization, which has led to greater awareness of chronic and age-related conditions like heart disease. The availability of more accurate and affordable diagnostic tools is empowering general practitioners to screen and refer patients for specialized cardiac evaluations earlier in the disease cycle. Advancements in veterinary pharmaceuticals-especially in areas like ACE inhibitors, beta blockers, diuretics, and novel heart medications-are enabling more effective long-term management of cardiac conditions. The expansion of specialty care facilities and veterinary cardiology training programs is helping to bridge the gap in specialist access, particularly in urban centers. Furthermore, the growth of pet insurance coverage is making advanced cardiac care financially accessible to a larger client base. Research collaborations and clinical trials are also accelerating drug development and treatment protocols. Together, these factors are propelling veterinary cardiology from a niche specialty to a mainstream component of comprehensive pet healthcare, with growing influence on how clinics are structured, how veterinary professionals are trained, and how pet health is managed in the years to come.

SCOPE OF STUDY:

The report analyzes the Veterinary Cardiology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal Type (Companion Animals, Production Animals); Product (Pharmaceuticals, Diagnostics); Indication (Congestive Heart Failure, Myocardial Disease, Arrhythmias, Others); End-Use (Veterinary Hospitals & Clinics, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • ALBA Medical Systems, Inc.
  • Antech Diagnostics
  • Boehringer Ingelheim International
  • Bionet America
  • Ceva Sante Animale
  • Cronus Pharma
  • Dextronix
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • IDEXX Laboratories
  • IMV Technologies
  • Infiniti Medical
  • Jurox
  • Medtronic
  • Merck & Co., Inc.
  • Patterson Veterinary
  • Pet Cardiology
  • RHC Medical
  • Scapa Healthcare

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Veterinary Cardiology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiac Conditions in Aging Pets Throws the Spotlight on Specialized Veterinary Cardiology Services
    • Advancements in Diagnostic Imaging and ECG Technologies Strengthen the Business Case for Cardiology Integration
    • Increased Pet Owner Awareness of Heart Health Propels Growth in Preventive Cardiac Screening and Monitoring
    • Here's How Breed-Specific Genetic Predispositions Are Driving Adoption of Early Cardiac Evaluations
    • Expansion of Veterinary Specialty Clinics and Referral Hospitals Accelerates Demand for Cardiology Equipment
    • Integration of Telecardiology and Remote Diagnostics Expands Access to Expertise in Underserved Regions
    • Growth in Companion Animal Lifespans Sustains Long-Term Demand for Chronic Cardiac Disease Management
    • Widespread Adoption of Echocardiography and Doppler Imaging Enhances Diagnostic Accuracy and Clinical Confidence
    • Here's the Story Behind the Surge in Demand for Cardiac Medications and Evidence-Based Treatment Protocols
    • Increased Availability of Pet Insurance Encourages Pursuit of Advanced and Costlier Cardiology Procedures
    • Development of Wearable Monitoring Devices and AI Diagnostics Accelerates Innovation in Cardiac Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Veterinary Cardiology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Veterinary Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Companion Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Production Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Production Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Production Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Veterinary Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Congestive Heart Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Congestive Heart Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Congestive Heart Failure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Myocardial Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Myocardial Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Myocardial Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Arrhythmias by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • JAPAN
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • CHINA
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • EUROPE
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Veterinary Cardiology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • FRANCE
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • GERMANY
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 134: UK Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Spain 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Veterinary Cardiology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Australia 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • INDIA
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 209: India Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: India 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: South Korea 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Veterinary Cardiology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Latin America 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Argentina 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Brazil 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Mexico 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Latin America 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Veterinary Cardiology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Middle East 15-Year Perspective for Veterinary Cardiology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Iran 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Israel 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Saudi Arabia 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: UAE 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Middle East 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030
  • AFRICA
    • Veterinary Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Veterinary Cardiology by Animal Type - Companion Animals and Production Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: Africa 15-Year Perspective for Veterinary Cardiology by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Production Animals for the Years 2015, 2025 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Veterinary Cardiology by End-Use - Other End-Uses and Veterinary Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Veterinary Cardiology by End-Use - Percentage Breakdown of Value Sales for Other End-Uses and Veterinary Hospitals & Clinics for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Veterinary Cardiology by Product - Pharmaceuticals and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Veterinary Cardiology by Product - Percentage Breakdown of Value Sales for Pharmaceuticals and Diagnostics for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Veterinary Cardiology by Indication - Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Veterinary Cardiology by Indication - Percentage Breakdown of Value Sales for Congestive Heart Failure, Myocardial Disease, Arrhythmias and Other Indications for the Years 2015, 2025 & 2030

IV. COMPETITION